ALK-Abellos A/S, of Copenhagen, Denmark, said its partner for Japan, Torii Pharmaceutical Co. Ltd., of Tokyo, reported positive results from its phase II/III trial of sublingual allergy immunotherapy tablet (SLIT-tablet) for Japanese cedar tree pollen allergic rhinitis (hay fever).